Skip to main content
Top
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Polio Virus | Research

Effective partnership and in-country resource mobilization in Sudan for cVDPV2 outbreak response amid multiple emergencies in 2020–2021

Authors: Mohammed Taufiq Mashal, Dalya Eltayeb, Ariel Higgins-Steele, Ismael Suleiman El Sheikh, Ni’ma Saeed Abid, Hemant Shukla, Leonard Machado, Hamid Jafari

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

During 2020 and immediately prior to the COVID-19 pandemic, Sudan was experiencing multiple emergencies including violence, seasonal flooding, and vector-borne disease outbreaks. After more than ten years since its last case of wild poliovirus, Sudan declared a circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreak on 9 August 2020.

Methods

cVDPV2 outbreak response data and programme documents of the Federal Ministry of Health and WHO were reviewed. Surveillance data was verified through WHO-recommended procedures for detecting and characterizing polioviruses from stool and sewage samples collected from acute flaccid paralysis (AFP) cases and the environment.

Results

This outbreak in Sudan led to a total of 58 confirmed cases of cVDPV2 from 15 of the 18 states. Two nationwide vaccination campaigns were held to increase immunity of children under-five against poliovirus type 2. Funding challenges were overcome by intense additional resource mobilization from in-country sources. The funding gap was bridged from domestic resources (49%) sourced through GPEI partners, and in-country humanitarian funding mechanisms.

Conclusions

During an outbreak response and challenge of funding shortfall, mobilizing in-country resources is possible through coordinated approaches, regular communication with partners, disaggregation of needs, and matching in-kind and financial support to fill gaps. A cVDPV2 outbreak requires a fast, resourced, and quality response to stop virus circulation.
Literature
1.
go back to reference Thompson KM. Poliovirus vaccine options: another step forward. The Lancet. 2020;397:2–3.CrossRef Thompson KM. Poliovirus vaccine options: another step forward. The Lancet. 2020;397:2–3.CrossRef
2.
go back to reference Alleman MM, Jorba J, Henderson E, et al. Update on vaccine-derived Poliovirus Outbreaks — Worldwide, January 2020–June 2021. MMWR Morb Mortal Wkly Rep. 2021;70(49):1691–9.CrossRefPubMedPubMedCentral Alleman MM, Jorba J, Henderson E, et al. Update on vaccine-derived Poliovirus Outbreaks — Worldwide, January 2020–June 2021. MMWR Morb Mortal Wkly Rep. 2021;70(49):1691–9.CrossRefPubMedPubMedCentral
4.
go back to reference Hampton LM, Farrell M, Ramirez-Gonzalez A, et al. Cessation of trivalent oral poliovirus vaccine and introduction of inactivated poliovirus vaccine— worldwide, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:934–38.CrossRefPubMed Hampton LM, Farrell M, Ramirez-Gonzalez A, et al. Cessation of trivalent oral poliovirus vaccine and introduction of inactivated poliovirus vaccine— worldwide, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:934–38.CrossRefPubMed
5.
go back to reference Macklin GR, O’Reilly KM, Grassly NC, et al. Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine. Science. 2020;368:401–05.CrossRefPubMed Macklin GR, O’Reilly KM, Grassly NC, et al. Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine. Science. 2020;368:401–05.CrossRefPubMed
7.
go back to reference Duintjer Tebbens RJ, Pallansch MA, Kew OM, et al. Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication. Risk Anal. 2006;26:1471–505.CrossRef Duintjer Tebbens RJ, Pallansch MA, Kew OM, et al. Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication. Risk Anal. 2006;26:1471–505.CrossRef
8.
go back to reference Cooper LV, Bandyopadhay AS, Gumede N, et al. Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa. The Lancet Infect Dis. 2022;22(2):284–94.CrossRefPubMed Cooper LV, Bandyopadhay AS, Gumede N, et al. Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa. The Lancet Infect Dis. 2022;22(2):284–94.CrossRefPubMed
13.
go back to reference Tuma J, Wilkinson AL, Diop OM, et al. Surveillance to track progress towards eradication worldwide, 2019–2020. MMWR. 2021;70(18):667–73.PubMedPubMedCentral Tuma J, Wilkinson AL, Diop OM, et al. Surveillance to track progress towards eradication worldwide, 2019–2020. MMWR. 2021;70(18):667–73.PubMedPubMedCentral
15.
go back to reference Eltayeb EM, Haithami SS, El Sayed EA. Combating an outbreak of poliomyelitis in Sudan following wild poliovirus importation: a success story. Sud J Public Health. 2006;1(2):135–8. Eltayeb EM, Haithami SS, El Sayed EA. Combating an outbreak of poliomyelitis in Sudan following wild poliovirus importation: a success story. Sud J Public Health. 2006;1(2):135–8.
20.
go back to reference Pirio GA, Kaufmann J. Polio eradication is just over the horizon: the challenges of global resource mobilization. J Health Commun. 2010;15(suppl 1):66–83.CrossRefPubMed Pirio GA, Kaufmann J. Polio eradication is just over the horizon: the challenges of global resource mobilization. J Health Commun. 2010;15(suppl 1):66–83.CrossRefPubMed
21.
go back to reference Thompson KM, Kalkowska DA, Badizadegan K. Polio health economics: assessing the benefits and costs of polio, non-polio, and integrated activities of the global Polio Eradication Initiative. Gates Open Res. 2022;6:5.CrossRefPubMedPubMedCentral Thompson KM, Kalkowska DA, Badizadegan K. Polio health economics: assessing the benefits and costs of polio, non-polio, and integrated activities of the global Polio Eradication Initiative. Gates Open Res. 2022;6:5.CrossRefPubMedPubMedCentral
23.
go back to reference Mohammed A, Tomori O, Nkengosong JN. Lessons from the elimination of poliomyelitis in Africa. Nat Reviews Imm. 2021;21:823–8.CrossRef Mohammed A, Tomori O, Nkengosong JN. Lessons from the elimination of poliomyelitis in Africa. Nat Reviews Imm. 2021;21:823–8.CrossRef
Metadata
Title
Effective partnership and in-country resource mobilization in Sudan for cVDPV2 outbreak response amid multiple emergencies in 2020–2021
Authors
Mohammed Taufiq Mashal
Dalya Eltayeb
Ariel Higgins-Steele
Ismael Suleiman El Sheikh
Ni’ma Saeed Abid
Hemant Shukla
Leonard Machado
Hamid Jafari
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-023-15675-y

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue